Advanced sequencing technology for cancer analysis
Official title: Fourth-Generation Nanopore-Assisted Sequencing for Advanced Oncological Analyses
Funded at Electronic Biosciences, INC. · NIH-11006600 · Data updated 2026-11-12
This study is working on a new way to read the genetic information related to cancer, which could help doctors find important details about your cancer and create better, personalized treatment plans just for you.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Electronic Biosciences, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $400,000 |
| NIH project number | 1R43CA295247-01 |
| Project ID | NIH-11006600 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with a history of cancer or those at high risk for developing cancer due to genetic factors.
✕Less likely to help
Patients with non-genetic forms of cancer or those who do not have a family history of cancer may not benefit from this research.
What this research studies
This research focuses on developing a new sequencing technology that uses nanopore-based methods to analyze cancer-related genomic variations. By improving the accuracy of sequencing, especially in complex regions of the genome that are often overlooked, this approach aims to provide a more comprehensive understanding of cancer genetics. The methodology involves detecting genomic variations on a single molecule basis, which allows for longer reads and better context of the genetic information. This could lead to more effective cancer screening and personalized treatment options in the future.
Why it matters
Potential benefit: If successful, this research could enable more accurate and accessible cancer screening, leading to earlier detection and better treatment outcomes for patients.
How similar studies have gone: Previous research has shown promise in using nanopore sequencing for genomic analysis, indicating potential for success in this novel approach.
Where this research is happening
-
Electronic Biosciences, INC.
San Diego, United States Active
Researchers
- Principal investigator: Peterson, Eric Mayo — Electronic Biosciences, INC.
- Study coordinator: Peterson, Eric Mayo
Related research
Other NIH-funded projects on the same topics.
-
Enabling protein sequencing with tiny nanopores
A new technology aims to read the exact amino acid sequence of a single protein molecule in real time using tiny protein-based pores.
-
Next-gen single-molecule protein sequencing for cancer profiling
A new single-molecule protein sequencing platform aims to directly read cancer-related proteins with ultra-high accuracy and through- put to reveal variants and modifications.
-
High-Fidelity DNA Sequencing of FMR1 CGG Repeats and Methylation in Fragile X
A new method will be developed to precisely measure CGG repeats and DNA methylation in the FMR1 gene to improve diagnosis and understanding of Fragile X–related autism.
-
At-home testing for prostate cancer using PSA levels
This study is working on a new, easy-to-use home testing device that helps men check their PSA levels for early signs of prostate cancer, making it simpler and more affordable for everyone to take care of their prostate health.
-
Developing a new method for sequencing proteins using enzymes
This study is working on a new way to read proteins one at a time, which could help doctors get better information about diseases and improve tests for patients, especially for those with rare or complicated proteins.
-
Developing advanced RNA sequencing technologies to understand gene expression and modifications.
This study is working on new ways to read RNA directly, which helps us see how genes work and how changes in RNA can affect our cells, making it easier to understand diseases and improve treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.